Samara Rosenfeld

It is feasible to discontinue methotrexate in patients who had received tofacitinib combination therapy.

Adjusting lifestyle factors can reduce the risk of gout in men.

Findings indicate placebo responses are more than a psychological placebo effect.

Three key issues with using the technology over in-person visits.

How rheumatologists use telemedicine during COVID-19.

Leveraging telemedicine during COVID-19.

An expert explains resources for pain related to rheumatic conditions.

An expert discusses the state of screening, diagnosing, and treating osteoarthritis and osteoporosis.

Which composite measures detect the highest level of changes in psoriatic disease activity.

How providers of multiple specialists can come together to help 1 patient.

An expert dermatologist explains.

A majority of patients with the condition are on azathioprine or mycophenolate mofetil and mycophenolic acid.

When a rheum patient might need to consult with a dermatologist.

The investigational JAK inhibitor filgotinib―which is under study as a treatment for a number of rheumatic diseases―has been shown to be safe and well tolerated in psoriatic arthritis patients.

How the 2 specialties play a role in each other.

Filgotinib was well-tolerated and sustained efficacy in a 52-week extension study.

Alternate therapies can be more effective than opioids.

There were no new safety signals and efficacy was sustained through 156 weeks.

Facets of managing pain for rheumatology patients.

Early initiation following fragility fractures helps manage osteoporosis.

This is the first time such an algorithm was validated in a large US claims database.

It is necessary to continue urate-lowering therapy in the inpatient setting to decrease the risk of gout flare in hospitalized patients.

The ICD-10 code for nr-ax-SpA should be programmed into EHRs in October.

There are not typical diagnostic criteria used to diagnose nr-ax-SpA.

Patients and clinicians alike will have a better understanding of clinical processes.

Jeff Stark, MD, discusses how ICD-10 codes for nr-ax-SpA affect patients and providers.

Jeff Stark, MD, discusses why nr-ax-SpA wasn't indexed and the process of having it included as an ICD-10 code.

With nr-ax-SpA newly identified as an ICD-10 code, Jeff Stark, MD, discusses why this is so important for patients and clinicians alike.

It is important for clinicians considering prescribing denosumab treatment to counsel patients before its initiation on the importance of not delaying or discontinuing injections.